AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
J Allergy Clin Immunol. 2016 Sep;138(3):860-868. doi: 10.1016/j.jaci.2016.02.026. Epub 2016 Apr 7.
Neutrophils are key effectors against the widely distributed mold Aspergillus fumigatus, which is a major threat for immunocompromised patients, including allogeneic hematopoietic stem cell transplant (HSCT) recipients. Yet little is known about neutrophil activity over time after cell transplantation, especially regarding A fumigatus.
We aimed at assessing the activity of neutrophils on A fumigatus in allogeneic HSCT recipients at different posttransplantation time points.
We performed a longitudinal study involving 37 patients undergoing HSCT, drawing blood samples at engraftment and at 2, 6, and 10 months after the HSCT. Posttransplantation neutrophil activity in the recipients was compared with that of the respective donors. Neutrophil/A fumigatus coculture, flow cytometry, and video microscopy were used to assess neutrophil inhibition of fungal growth, cell/fungus interactions, reactive oxygen species production, major surface molecule expression, and neutrophil extracellular trap (NET) formation.
The ability of neutrophils to interfere with Aspergillus species hyphal growth was impaired after HSCT. The administration of calcineurin inhibitors appeared to play an important role in this impairment. We also observed that post-HSCT neutrophils produced less NETs, which was correlated with increased fungal growth. Tapering immunosuppression led to the recuperation of inhibition capacity 10 months after HSCT.
In HSCT recipients neutrophil-driven innate immunity to fungi is altered in the early posttransplantation period (between recovery from neutropenia and up to 6 months). This alteration is at least partly related to administration of calcineurin inhibitors and diminution of NETs production.
中性粒细胞是对抗广泛分布的霉菌烟曲霉的关键效应物,烟曲霉对包括异基因造血干细胞移植(HSCT)受者在内的免疫功能低下患者构成重大威胁。然而,人们对细胞移植后中性粒细胞活性随时间的变化知之甚少,特别是关于烟曲霉。
我们旨在评估不同移植后时间点异基因 HSCT 受者对烟曲霉中性粒细胞的活性。
我们进行了一项纵向研究,纳入 37 名接受 HSCT 的患者,在植入和 HSCT 后 2、6 和 10 个月时采集血样。将移植后受者的中性粒细胞活性与各自供者进行比较。使用中性粒细胞/烟曲霉共培养、流式细胞术和视频显微镜评估中性粒细胞对真菌生长的抑制作用、细胞/真菌相互作用、活性氧物质产生、主要表面分子表达和中性粒细胞胞外陷阱(NET)形成。
HSCT 后,中性粒细胞干扰烟曲霉属菌丝生长的能力受损。钙调神经磷酸酶抑制剂的给药似乎在这种损伤中起重要作用。我们还观察到,移植后中性粒细胞产生的 NET 减少,这与真菌生长增加有关。免疫抑制药物的逐渐减量导致 10 个月后 HSCT 后抑制能力的恢复。
在 HSCT 受者中,移植后早期(中性粒细胞恢复至正常水平至 6 个月内)中性粒细胞介导的抗真菌固有免疫发生改变。这种改变至少部分与钙调神经磷酸酶抑制剂的给药和 NET 产生减少有关。